
Thomas H. Kean Periodic Transaction Report
Filed Jan 26, 2024 · House Clerk · 1 transaction
U.S. Representative · R · NJ-07 · All trades by Thomas H. Kean
On January 26, 2024, Rep. Thomas H. Kean (R-NJ-07) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 purchase) dated Dec 14, 2023.
The filing covers 1 ticker, including $ORCL.
Reported amount ranges sum to $1K–$15K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 43 days.
Source document: House Clerk filing 20024309
Sample · the intelligence layer
Thomas H. Kean · Bought $ORCL · Dec 14 · $1K–$15K
1 other member traded this name in the same window.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Thomas H. Kean
Get an email the moment Thomas H. Kean files the next one. Free, no card, no spam.
Tickers in this filing
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Dec 14, 2023 | ORCLORCLOracle Corporation | Oracle Corporation (ORCL) | buy | — | $1K–$15K | 43d |
The line under an asset name is the asset type the filer selected on the House form, shown with the House Clerk's label for that code. It is the filer's coding, not a classification by Coldpine.
Other recent filings by Thomas H. Kean
- PTR filed Apr 13, 20268 trades · AMCR, CB, FCNCA, JNJ
- PTR filed Mar 18, 20266 trades · FCNCA, GOOGL, LIN, WAT
- PTR filed Feb 19, 20266 trades · ABT, GM, JNJ, MKL
- PTR filed Jan 16, 20264 trades · LLYVA, LLYVK, SNREY
- PTR filed Dec 19, 20253 trades · JNJ, SYK, TXN
- PTR filed Nov 17, 20252 trades · FISV
← All congressional filings, newest firstFiled Jan 26, 2024January 2024 archive
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →